[Xingyuan Environment invested in the establishment of a new energy company, including battery-related business].
According to the Qichacha APP, Zhejiang Xinzhi New Energy was established with a registered capital of 10 million yuan. Its business scope includes battery manufacturing, research and development of emerging energy technologies, sales of battery spare parts, battery sales, sales of special equipment for semiconductor devices, leasing of photovoltaic power generation equipment, manufacturing of photovoltaic equipment and components, etc. According to the equity penetration of Qichacha, the company is wholly owned by Xingyuan Environment.
Hetai Electromechanical: Net profit in 2023 will decrease by 48 year-on-year47% 10 to 125 yuan].
Hetai Electromechanical (001225) released its annual report on the evening of February 21. According to the report, the company's operating income in 2023 will be 38.6 billion yuan, down 22 percent from the adjusted period last year35%；Net profit was 11.4 billion yuan, down 4847%；Basic earnings per share were 184 yuan. The company plans to pay a dividend of 12. for every 10 shares5 yuan (tax included).
The first imported down and feather inspection site in Beibu Gulf Port was officially put into use
According to Beibu Gulf Port, on February 20, the Beiji Division Inbound Down and Feather Supervision Site was officially put into use, which is the first site for imported down and feather inspection in Beibu Gulf Port. The inspection yard can accommodate 10 40-foot containers at the same time to carry out inspection operations, providing more convenient and efficient inspection services for imported down and feathers.
Accelink and others set up a new venture capital private equity company with more than 100 million yuan
Recently, SIEMIC proof-of-concept angel venture capital** (Wuhan) partnership (limited partnership) has been established, and the executive partner is Wuhan Optics Valley Fiberhome Investment** management *** registered capital of 11.5 billion yuan. The company's business scope covers venture capital, which is limited to investing in unlisted enterprises, and engages in equity investment, investment management, asset management and other activities with private equity**. According to the equity penetration of Qichacha, the company is jointly held by Accelink and others.
Fu'an Pharmaceutical: Cefoperazone sodium for injection and sulbactam sodium passed the consistency evaluation
Fu'an Pharmaceutical (300194) announced on the evening of February 21 that Qingyutang Pharmaceutical, a wholly-owned subsidiary of the company, recently received the approval notice of supplementary application for cefoperazone sodium sulbactam sodium for injection issued by the State Food and Drug Administration, and the drug passed the consistency evaluation of generic drug quality and efficacy. The drug is mainly suitable for upper and lower respiratory tract infections, urinary tract infections, sepsis, peritonitis, soft tissue infections, bone and joint infections, pelvic inflammatory disease, endometritis and other infectious diseases caused by sensitive bacteria.
Oriental Jiasheng: This year, the medical sector will continue to recruit business teams to increase distribution product lines
Oriental Jiasheng said in an institutional survey on February 21 that this year, the medical sector will continue to recruit medical business teams and increase medical distribution product lines, such as early cancer screening, medical beauty, dentistry, orthopedic medical devices, etc.; Provide customers with more value-added services for the processing line in the warehouse, such as the simple assembly of reagent products in the warehouse of the current foreign head customers. The company will also explore and develop the needs of the world's top 20 multinational companies and domestic leading enterprises in the field of life science and medical health, and provide customers with high-quality and efficient integrated digital medical ** chain comprehensive services.